Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-01-17 Bencherif Merouane SVP and Senior Scien Fellow Grant or award · Stock Option (Right to Buy) +40,000 40,000
2012-05-18 Bencherif Merouane SVP, Preclinical Research Exercise or conversion +15,938 $2.93 $47K 15,938
2012-05-18 Bencherif Merouane SVP, Preclinical Research Exercise or conversion · Stock Option (Right to Buy) −15,938 7,970
2012-05-04 Bencherif Merouane SVP, Preclinical Research Grant or award · Stock Option (Right to Buy) +90,000 90,000

Page 1 of 1 · 4 trades